2013 International Symposium on Hodgkin Lymphoma

Advertisement

Advertisement



Aug
17
Today In Oncology
FDA Approves Lenvatinib for Unresectable Hepatocellular Carcinoma
Issues in Doctor-Patient Discussions on Potential Harms of Lung Cancer Screening
VB4-845 Granted Fast Track Designation by FDA for Treatment of Non–Muscle Invasive Bladder Cancer
Basal Cell Carcinoma and Risk for Development of Other Cancers
Broad-Based Genomic Sequencing in Advanced NSCLC in the Community Oncology Setting
View More 
;
Advertisement
Most Read Stories
No Benefit of Adding Abiraterone to Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Increasing PSA
FDA Grants Breakthrough Device Designation for Cancer Detection Liquid Biopsy
Why Oncologists Should Decline to Participate in the Right to Try Act
Definitive Pelvic Radiation Therapy Plus Chemotherapy and Survival in Newly Diagnosed Metastatic Cervical Cancer
Prognostic Model for Treatment Outcomes in BRAF V600–Mutated Metastatic Melanoma
View More 
Most Viewed Videos
Bruce D. Cheson, MD, and Richard I. Fisher, MD, on Lymphoma: Treatment Considerations
Sherry Shen, MD, on Breast Cancer and Obesity: Results of the SWOG S0927 Study
Jonathan W. Friedberg, MD, on Follicular Lymphoma: Novel Combination Therapies
Nathan A. Pennell, MD, PhD, on NSCLC: Lowering Genetic Testing Costs
Susan M. O’Brien, MD, on CLL: Sequencing Therapy Options
View More 
© 2018 HSP News Service, L.L.C.
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.